Details for New Drug Application (NDA): 065286
✉ Email this page to a colleague
NDA 065286 describes AZTREONAM, which is a drug marketed by Fresenius Kabi Usa, Hikma, and Hospira, and is included in three NDAs. It is available from two suppliers. Additional details are available on the AZTREONAM profile page.
The generic ingredient in AZTREONAM is aztreonam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aztreonam profile page.
The generic ingredient in AZTREONAM is aztreonam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aztreonam profile page.
Medical Subject Heading (MeSH) Categories for 065286
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
| Approval Date: | Mar 23, 2011 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
| Approval Date: | Mar 23, 2011 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
